Latest & greatest articles for cardiovascular disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cardiovascular disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cardiovascular disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cardiovascular disease

601. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review

Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review Warren-Gash C, Smeeth L and Hayward AC CRD summary This review investigated whether influenza vaccines provided protection against cardiac events and concluded (...) that there was some evidence that influenza vaccines were effective at reducing the risk of cardiac events in patients with established cardiovascular disease. Potential for error and bias, unclear study quality and possible inappropriate pooling of studies suggested that these conclusions should be viewed with caution. Authors' objectives To examine the effectiveness of influenza vaccines at protecting against cardiac events and to review the evidence that influenza triggers acute myocardial infarction

DARE.2009

602. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease

The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease North CJ, Venter CS, Jerling JC CRD summary This review found that in the presence of weight loss and modified saturated, monounsaturated and polyunsaturated fatty acid (...) fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. European Journal of Clinical Nutrition 2009; 63(8): 921-933 PubMedID DOI Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Adult; Biomarkers /blood; C-Reactive Protein /metabolism; Clinical Trials as Topic; Dietary Fats; Dietary Fiber /administration & Humans; Inflammation /blood; Weight Loss; dosage /pharmacology AccessionNumber 12009108530 Date bibliographic record published 11/11/2009

DARE.2009

603. Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis

Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis Rodrigo GJ, Castro (...) -Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA CRD summary This review evaluated the safety of inhaled tiotropium bromide (anticholinergic agent) in patients with chronic obstructive pulmonary disease. The authors concluded that tiotropium did not significantly increase the risk of adverse major cardiovascular events compared with placebo or salmeterol. The authors' conclusions reflected the evidence presented, but lack of clarity regarding included trial quality means that their reliability

DARE.2009

605. Effect of smoking cessation advice on cardiovascular disease

Effect of smoking cessation advice on cardiovascular disease Effect of smoking cessation advice on cardiovascular disease Effect of smoking cessation advice on cardiovascular disease Eddy DM, Peskin B, Shcheprov A, Pawlson G, Shih S, Schaaf D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. CRD summary This study evaluated the effect of providing advice about the importance of smoking cessation and the availability of counselling and medication in the prevention of morbidity, mortality, and costs related to cardiovascular disease. The authors concluded that the provision of this advice reduced the associated morbidity, mortality and costs. The methods appear to have been satisfactory, but the data sources were not fully described

NHS Economic Evaluation Database.2009

606. Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina Rubinstein A, Garcia Marti S, Souto A, Ferrante D, Augustovski F Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of interventions to decrease cardiovascular disease. Lowering salt intake, mass media health education, and a polypill for people with a 20% or greater risk were the most cost-effective strategies

NHS Economic Evaluation Database.2009

607. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea

Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine (...) and atorvastatin for the primary prevention of cardiovascular disease in Korea Liew D, Park HJ, Ko SK Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of a single-tablet fixed-dose combination of amlodipine

NHS Economic Evaluation Database.2009

608. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions

Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions Results of a Markov model (...) analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions Kang HY, Ko SK, Liew D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study

NHS Economic Evaluation Database.2009

609. Association between depressive symptoms and cardiovascular events in people with coronary heart disease largely due to physical inactivity

Association between depressive symptoms and cardiovascular events in people with coronary heart disease largely due to physical inactivity Association between depressive symptoms and cardiovascular events in people with coronary heart disease largely due to physical inactivity | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Association between depressive symptoms and cardiovascular events in people with coronary heart disease largely due to physical inactivity Article Text Prognosis Association between depressive symptoms and cardiovascular events

Evidence-Based Mental Health2009

610. Magical numbers in pharmacological prevention of cardiovascular disease and fractures. A critical appraisal

Magical numbers in pharmacological prevention of cardiovascular disease and fractures. A critical appraisal Volumen 17. DTB Navarre. Vol 17, No 4. August - October 2009 - navarra.es Castellano | Euskara | Français | English Use the search tool! Search engine : : : : : : : : DTB Navarre. Vol 17, No 4. August - October 2009 DTB Navarre. Vol 17, No 4. August - October 2009 Content tools Share it Magical numbers in pharmacological prevention of cardiovascular disease and fractures. A critical

Drug and Therapeutics Bulletin of Navarre (Spain)2009

611. Does IQ predict total and cardiovascular disease mortality as strongly as other risk factors? Comparison of effect estimates using the Vietnam Experience Study

Does IQ predict total and cardiovascular disease mortality as strongly as other risk factors? Comparison of effect estimates using the Vietnam Experience Study 18801778 2008 11 17 2009 01 27 2017 02 20 1468-201X 94 12 2008 Dec Heart (British Cardiac Society) Heart Does IQ predict total and cardiovascular disease mortality as strongly as other risk factors? Comparison of effect estimates using the Vietnam Experience Study. 1541-4 10.1136/hrt.2008.149567 To compare the strength of the relation (...) of two measurements of IQ and 11 established risk factors with total and cardiovascular disease (CVD) mortality. Cohort study of 4166 US male former army personnel with data on IQ test scores (in early adulthood and middle age), a range of established risk factors and 15-year mortality surveillance. When CVD mortality (n = 61) was the outcome of interest, the relative index of inequality (RII: hazard ratio; 95% CI) for the most disadvantaged relative to the advantaged (in descending order

EvidenceUpdates2009 Full Text: Link to full Text with Trip Pro

612. Systematic review: glucose control and cardiovascular disease in type 2 diabetes

Systematic review: glucose control and cardiovascular disease in type 2 diabetes Systematic review: glucose control and cardiovascular disease in type 2 diabetes Systematic review: glucose control and cardiovascular disease in type 2 diabetes Kelly T N, Bazzano L A, Fonseca V A, Thethi T K, Reynolds K, He J CRD summary This review found that intensive glucose control reduced the risk for some cardiovascular disease outcomes in patients with type 2 diabetes (e.g. non-fatal myocardial infarction (...) (RCT) search filter. Search terms were reported. Reference lists were also searched and experts were contacted. Study selection RCTs of adults (19 years or older) with type 2 diabetes were eligible for inclusion, if they compared an intensive glucose control group with a conventional treatment group (with a priori specification of glycaemic goals for both groups). Clinical cardiovascular disease needed to be the primary end-point and the sample size had to be at least 500 patients. The included

DARE.2009

613. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised (...) so that drugs are offered to people with all levels of blood pressure. The authors stated that consideration should be given to replacing current policies that focus on routine measuring of blood pressure with policies that focus on routinely lowering blood pressure. Research: The authors did not state implications for research. Funding Not stated. Bibliographic details Law M R, Morris J K, Wald N J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis

DARE.2009

614. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials Berger J S, Krantz M J, Kittelson J M, Hiatt W R CRD summary This review found that aspirin (...) treatment in patients with peripheral artery disease provided a statistically significant reduction in nonfatal stroke but not in cardiovascular events. The authors also concluded that given the limited statistical power of their analysis, further randomised controlled trials are required. These cautious conclusions are likely to be reliable. Authors' objectives To assess the effect of aspirin on cardiovascular event rates in patients with peripheral artery disease. Searching MEDLINE, Cochrane Central

DARE.2009

615. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils

Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils Mozaffarian D (...) validity. Data extraction RCTs : Outcome data were extracted to permit the calculation of differences in blood lipid measures between intervention groups. Cohort studies : Data were extracted on the adjusted risk ratio for CHD per 2% more energy from trans-fatty acids. Adjustments were made for other cardiovascular risk factors and lifestyle habits. The authors did not state how many authors extracted the data. Methods of synthesis RCTs : Meta-variable regression analyses, stratified by gender, were

DARE.2009

616. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials Brugts J J (...) , Yetgin T, Hoeks S E, Gotto A M, Shepherd J, Westendorp R G, de Craen A J, Knopp R H, Nakamura H, Ridker P, van Domburg R, Deckers J W CRD summary This generally well-conducted review concluded that statin use in patients without established cardiovascular disease, but with cardiovascular risk factors, was associated with significantly improved survival and large reductions in the risk of major cardiovascular events. This conclusion reflected the results of an appropriate synthesis of large, high

DARE.2009

617. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis (...) for clinical outcomes of interest. Data was extracted using standardised pre-piloted data extraction forms. In extracting data regarding coronary heart disease death, the hierarchy used was: coronary heart disease death; fatal myocardial infarction; fatal cardiac events; fatal cardiovascular events. Where trials had multiple treatment arms, the control group was used as comparator for all treatment arms. Two reviewers independently extracted data from the included studies Methods of synthesis Studies were

DARE.2009

618. [Systematic review of the effects of home telemonitoring in the context of diabetes, pulmonary diseases and cardiovascular diseases]

[Systematic review of the effects of home telemonitoring in the context of diabetes, pulmonary diseases and cardiovascular diseases] Revue systematique des effets de la telesurveillance a domicile dans le contexte du diabete, des maladies pulmonaires et des maladies cardiovasculaires [Systematic review of the effects of home telemonitoring in the context of diabetes, pulmonary diseases and cardiovascular diseases] Revue systematique des effets de la telesurveillance a domicile dans le contexte (...) du diabete, des maladies pulmonaires et des maladies cardiovasculaires [Systematic review of the effects of home telemonitoring in the context of diabetes, pulmonary diseases and cardiovascular diseases] Pare G, Moqadem K, Pineau G, St-Hilaire C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pare G, Moqadem K, Pineau G, St-Hilaire C. Revue

Health Technology Assessment (HTA) Database.2009

619. Guidelines for the assessment of absolute cardiovascular disease risk

Guidelines for the assessment of absolute cardiovascular disease risk Absolute risk | The Heart Foundation Submit search Absolute risk Absolute risk resources for health professionals Guidelines and tools Information for your patients Absolute cardiovascular disease risk is the numerical probability of a cardiovascular event occurring within a five-year period. It reflects a person's overall risk of developing cardiovascular disease (CVD) replacing the traditional method that considers various (...) years. Risk charts The provide an alternative to calculate risk in the form of printable colour charts to use in your practice. Guidelines for the management of absolute cardiovascular disease risk National Vascular Disease Prevention Alliance (NVDPA) resources The Heart Foundation is a member of the National Vascular Disease Prevention Alliance (NVDPA). The alliance was formed to reduce the burden of cardiovascular disease (CVD) in Australia and is made up of the National Stroke Foundation

National Health and Medical Research Council2009

620. An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 dia

An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 dia An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 diabetes | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 diabetes Article Text Treatment

Evidence-Based Nursing (Requires free registration)2009